As an organization that has been funding HIV/AIDS research since 1995, we at The Campbell Foundation know the harsh realities of successes and failures in the lab. It can be a one-step forward, two steps back process. So, when a researcher we fund makes important and newsworthy headlines, we are always excited to be a part of it. This week, Dr. Susana Valente, a researcher with The Scripps Research Institute in Florida, along with her colleagues, have shown for the first time

In our previous blog we wrote about The Campbell Foundation’s funding of organizations in South Florida and around the country that provide much-needed services to those with HIV and AIDS, as well as to their families. We do this through our annual “Holiday Hug” program at the end of each year. It is our way of saying thanks for everything they do to help those in need. We asked some of those organizations to share what that funding has meant to them and we received a number

Although The Campbell Foundation’s main focus has always been to provide researchers with funding to discover better treatments for people with HIV, as well as research into a cure for HIV, each year we also provide smaller grants to organizations whose mission is to assist those with the disease. What many people may not realize is that those with HIV and AIDS face many other social and economic barriers. Some may not have transportation to get to their doctor appointments;

News reports have surfaced in recent weeks of how those with HIV are now living long enough to develop Alzheimer’s disease. The good news in all of this is that we have been able to develop medications and treatments to keep those with HIV and AIDS alive for significantly longer than ever before. The recent case making headlines involves a 71-year-old man with amyloid deposits in the brain that were detected by a PET scan. These deposits have been linked to Alzheimer’s diseas

It’s a new year and a new opportunity to fund enterprising and exciting research in the field of HIV/AIDS. We wrapped up 2015 on a high note, reaching the $1 million mark in funding to direct service organizations. But even more significantly, we reached the $10 million mark for total funding since The Campbell Foundation’s inception 21 years ago. That brings us to a new report recently released by Funders Concerned About AIDS (FCAA) which found that global private funding fo

Although The Campbell Foundation traditionally has focused on funding individual research, sometimes being part of something bigger makes sense. That’s one of the reasons we decided last year to provide amfAR with a $50,000 matching grant for HIV cure research. amfAR, like The Campbell Foundation, is dedicated to the support of HIV/AIDS research, so when they came to us with a proposal to provide a matching grant, it made sense. The Campbell Foundation could harness the power

In 2013, The Campbell Foundation provided an $86,431 grant to a team of researchers at the University of California Davis to develop a gene therapy strategy designed to generate an HIV-resistant immune system in patients. Joseph Anderson, principal investigator of the study and assistant professor of internal medicine at UC Davis, along with his team, modified human stem cells with genes that resist HIV infection. They then transplanted a near-purified population of these cel

Funding AIDS research isn’t just about finding a cure for the disease. Funding AIDS research means a lot more to us at The Campbell Foundation. When Richard Campbell Zahn established this foundation, it was his desire to not only support clinical laboratory-based research into the prevention and treatment of HIV/AIDS, but also conditions and illnesses that go along with the disease. Since 1995, The Campbell Foundation has funded alternative, nontraditional avenues of research